Women's hair loss isn't just male-pattern in pink: the hormonal panel that actually matters

If a woman walks into a dermatology visit complaining about hair loss and walks out with a single bottle of 5% minoxidil and no bloodwork, she got the partial answer.

Female-pattern hair loss is real, common (roughly 40 percent of women have meaningful hair thinning by 50), and almost never has a single cause. Treating it like a topical-only problem misses the half of the protocol that actually moves the needle.

Here's what a complete workup looks like — and why the panel matters more than the prescription.

The five drivers we look for.

1. Iron and ferritin. Low ferritin (the storage form of iron) is the single most common reversible cause of diffuse hair thinning in women. Many women run ferritin in the single digits or low teens — technically "normal" by the lab's loose reference range, but functionally deficient for hair growth. We want ferritin north of 50 ng/mL, and ideally closer to 70–100, before we even start a serious topical protocol.

2. Thyroid. Both hypo- and hyper-thyroidism cause hair loss. The full thyroid panel — TSH, free T3, free T4, and antibodies — needs to be in range. "TSH normal" on its own isn't the answer; many women with hair loss have a TSH of 3.5 and free T3 at the bottom of range.

3. Androgens (yes, in women). Elevated testosterone or DHT — typical of PCOS — drives the male-pattern thinning at the crown and frontal scalp. The standard female panel includes total and free testosterone, DHT, DHEA-S, and SHBG. If androgens are elevated, the protocol changes: we add spironolactone or oral minoxidil, and topical alone won't get us there.

4. Estradiol and the perimenopausal drop. Estradiol supports the anagen (growth) phase of the hair cycle. When it drops in perimenopause, more follicles fall into the telogen (resting) phase, and you see diffuse thinning across the whole scalp — different texture than androgenetic loss. HRT often helps this directly.

5. Stress, illness, and post-partum. Acute stressors push follicles into telogen effluvium — a synchronous shed that shows up 2–3 months after the event. Usually self-resolves within 6 months, but a good clinician identifies it so you don't get put on a chronic protocol you don't need.

The panel worth running.

DirectCare AI offers a clinician-ordered hair-and-hormone panel as part of our Blood Labs product. For women losing hair, the markers worth pulling include:

• CBC, ferritin, iron, transferrin saturation
• TSH, free T3, free T4, TPO antibodies
• Total testosterone, free testosterone, DHT, DHEA-S, SHBG
• Estradiol, progesterone, LH, FSH
• Vitamin D, B12, zinc
• Fasting glucose and insulin (insulin resistance drives PCOS-pattern loss)

That's the bloodwork that points to why you're losing hair — and which combination of fixes is going to actually work.

Topical protocols for women.

If the underlying drivers (iron, thyroid, hormones) are addressed, the topical that works for most women is a compounded formulation:

• Minoxidil 2–5% (we titrate up if tolerated)
• Sometimes spironolactone topical 2% for androgen-driven patterns
• Sometimes finasteride 0.05–0.1% for postmenopausal women under close monitoring
• Occasionally tretinoin 0.01% to improve absorption

Apply nightly to a dry scalp. Same realistic timeline as men: 3 months for the shed to settle, 6 months for visible change, 12+ for the full picture.

What we don't do.

• Promise regrowth at the hairline that isn't biologically possible. Long-standing recession rarely fully reverses.
• Prescribe oral finasteride to premenopausal women. (Different pharmacology question, much narrower indication.)
• Run a generic protocol without bloodwork.

Women's hair loss is multifactorial. The right protocol is multifactorial too. If your clinician is only handing you a bottle of minoxidil, you're getting one piece of a four-piece puzzle.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved as finished products; their active ingredients are individually FDA-approved. Always consult a US-licensed clinician before starting or changing any therapy.